Director Beverly Huss buys 25,900 IRIX shares at $1.22; 4 other insiders also bought in past 14 days
Beverly Huss, a director of IRIDEX CORP, purchased 25,900 shares at $1.22 on 2025-04-23, increasing her holdings by 38.8% from 66,739 to 92,639 shares and deploying $31,499.58. This transaction is part of a broader cluster pattern: 4 other insiders also purchased shares within the past 14 days, suggesting coordinated interest in accumulating equity at current levels. The company is unprofitable (net income of $-1,933,000.00 in the latest quarter) with revenue declining 6.2% year-over-year and a market cap of $19,475,271.32, yet the director chose to increase exposure—a positioning that contrasts sharply with the company's weak fundamentals. Notably, Huss's cross-ticker track record shows prior buys averaging -4.2% returns over 30 days and -11.5% over 90 days with a 0.00% 90-day win rate, warranting investor scrutiny of what has changed to motivate this material 38.8% position increase.